Lysergic acid methylamide (LAM), also known as N-methyllysergamide (NM-LA), is a serotonin receptor modulator of the lysergamide family related to the psychedelic drug lysergic acid diethylamide (LSD). It is the N-methyl derivative of ergine (lysergic acid amide; LSA) and the analogue of LSD in which the N,N-diethyl groups have been replaced with one N-methyl group. The drug is active in humans at a dose of approximately 500 μg and has roughly 20% of the potency of LSD as a drug. However, it has been said to produce autonomic effects but to produce no psychoactive or hallucinogenic effects at this dose. The drug has about 6.3% of the antiserotonergic potency of LSD in the isolated rat uterus in vitro. LAM was first described in the scientific literature by Albert Hofmann and colleagues by 1955.
See also Substituted lysergamide Lysergic acid amide (LSA; ergine) Lysergic acid ethylamide (LAE-32) Lysergic acid dimethylamide (DAM-57)
References
External links NM-LA - Isomer Design



